References
- de Koning HD, Bodar EJ, van der Meer JWM, Simon A. Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment. Semin Arthritis Rheum 2007;37:137–48.
- de Koning HD, Bodar EJ, Simon A, van der Hilst JCH, Netea MG, van der Meer JWM. Beneficial response to anakinra and thalidomide in Schnitzler's syndrome. Ann Rheum Dis 2006;65:542–4.
- Schneider SW, Gaubitz M, Luger TA, Bonsmann G. Prompt response of refractory Schnitzler syndrome to treatment with anakinra. J Am Acad Dermatol 2007;56:S120–1.
- Kluger N, Riviere S, Guillot B, Bessin D. Efficacy of interleukin 1 receptor antagonist (anakinra) on a refractory case of Schnitzler's syndrome. Acta Derm Venereol 2008;88:287–8.
- Wastiaux H, Barbarot S, Cagey-Caron V, Berthelot JM, Hamidou M, Stalder JF. Schnitzler syndrome: a dramatic improvement with anakinra. J Eur Acad Dermatol Venereol 2008;23:85–7.
- Martinez-Taboada VE, Fontalba A, Blanco R, Fernandez-Luna. Successful treatment of refractory Schnitzler syndrome with anakinra: comment on the article by Hawkins et al. Arthritis Rheum 2005;52:2226–7.
- Elling E, Moller M, Kreiselmaier I, Brasch J, Schwarz T. Schnitzler syndrome: treatment failure to rituximab but response to anakinra. J Am Acad Dermatol 2007;57:361–4.
- Besada E, Nossent H. Dramatic response to IL1-RA treatment in longstanding multidrug resistant Schnitzler's syndrome: a case report and literature review. Clin Rheumatol 2010;29:567–71.
- Schuster C, Kranke B, Aberer E, Arbab E, Sturm G, Aberer W. Schnitzler syndrome: response to anakinra in two cases and a review of the literature. Int J Dermatol 2009;48:1190–4.
- van Deuren M, Kroot JJ, Swinkels DW. Time-course analysis of serum hepcidin, iron and cytokines in a C282Y homozygous patient with Schnitzler's syndrome treated with IL-1 receptor antagonist. Haematologica 2009;94:1297–300.
- Devlin L, Wright G, Edgar JDM. A rare cause of a common syndrome, anakinra is effective in the urticaria of Schnitzler syndrome: a case report. Cases J 2008;24:348.
- Florez AF, Agromayor EG, Garcia-Barredo R, Alvaro RML, Angulo MG, Martinez-Taboada VM, Radiological aid to clinical diagnosis of Schnitzler's syndrome: multimodality imaging approach. Clin Rheumatol 2008;27:107–10.
- Thonhofer R, Uitz E, Graninger W. Schnitzler's syndrome: exacerbation after anti-TNF treatment. Rheumatology 2007;46:1041–2.
- Saiz E, Galvez J, Mora A, Contreras L. [Anakinra and Schnitzler's syndrome]. in Spanish. Med Clin (Barc) 2008;130:357–8.
- Dybowski F, Sepp N, Bergerhausen HJ, Braun J. Successful use of anakinra to treat refractory Schnitzler's syndrome. Clin Exp Rheumatol 2008;26:354–7.
- Treudler R, Kauer F, Simon JC. Striking effect of the IL-1 receptor antagonist anakinra to chronic urticarial rash with polyclonal increase in IgA and IgG. Acta Derm Venereol 2007;87:280–1.
- Crouch R, Akhras V, Sarkany R. Schnitzler's syndrome: successful treatment with anakinra. Australas J Dermatol 2007;48:178–81.
- Gilson M, Abad S, Larroche C, Dhote R. Treatment of Schnitzler's syndrome with anakinra. Clin Exp Rheumatol 2007;25:931.
- Ryan JG, de Koning HD, Beck LA, Booty MG, Kastner DL, Simon A. IL-1 blockade in Schnitzler syndrome: ex vivo findings correlate with clinical remission. J Allerg Clin Immunol 2008;121:260–2.
- Frischmeyer-Guerrerio PA, Rachamalla R, Saini SS. Remission of Schnitzler syndrome after treatment with anakinra. Ann Allergy Asthma Immunol 2008;2008;100:617–19.
- Varella TC, Nishimura MY, Machado MC, de Moraes-Vasconcelos D, Rivitti EA. Schnitzler's syndrome without monoclonal gammopathy. Acta Derm Venereol 2005;85:272–3.
- Lipsker D, Veran Y, Grunenberger F, Cribier B, Heid E, Grosshans E. The Schnitzler syndrome: four new cases and review of the literature. Medicine (Baltimore) 2001;80:37–44.
- Church LD, Cook GP, McDermott MF. Primer: inflammasomes and interleukin 1beta in inflammatory disorders. Nat Clin Pract Rheumatol 2008;4:34–42.